SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity
Background: The SARS-CoV-2 pandemic currently prevails worldwide. To understand the immunological signature of SARS-CoV-2 infections and aid the search and evaluation of new treatment modalities and vaccines, comprehensive characterization of adaptive immune responses towards SARS-CoV-2 is needed. M...
Main Authors: | Stine SF Nielsen, Line K Vibholm, Ida Monrad, Rikke Olesen, Giacomo S Frattari, Marie H Pahus, Jesper F Højen, Jesper D Gunst, Christian Erikstrup, Andreas Holleufer, Rune Hartmann, Lars Østergaard, Ole S Søgaard, Mariane H Schleimann, Martin Tolstrup |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396421002036 |
Similar Items
-
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses
by: Line K. Vibholm, et al.
Published: (2021-02-01) -
The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
by: Janne Tegder Martinsen, et al.
Published: (2020-06-01) -
Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency ex vivo without T cell activation
by: Jesper D. Gunst, et al.
Published: (2019-07-01) -
Immune checkpoints and the HIV-1 reservoir: proceed with caution
by: Rikke Olesen, et al.
Published: (2016-07-01) -
Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits Ex Vivo Lipopolysaccharide-Induced Inflammatory Responses
by: Christel Rothe Brinkmann, et al.
Published: (2018-02-01)